您的位置: 首页 > 农业专利 > 详情页

Combination of an ALK inhibitor and a CDK inhibitor for the treatment of cell proliferative diseases
专利权人:
Novartis AG
发明人:
Harris, Jennifer Leslie,Li, Nanxin,Smith, Timothy R.
申请号:
AU2014312261
公开号:
AU2014312261A1
申请日:
2014.08.28
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present invention relates to a pharmaceutical combination comprising, separately or together, (1) a first agent which is an ALK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof. The invention further relates the use of such combination in the treatment or prevention of proliferative diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充